Skip to main content
Top
Published in: Diabetologia 2/2019

Open Access 01-02-2019 | Short Communication

Afternoon exercise is more efficacious than morning exercise at improving blood glucose levels in individuals with type 2 diabetes: a randomised crossover trial

Authors: Mladen Savikj, Brendan M. Gabriel, Petter S. Alm, Jonathon Smith, Kenneth Caidahl, Marie Björnholm, Tomas Fritz, Anna Krook, Juleen R. Zierath, Harriet Wallberg-Henriksson

Published in: Diabetologia | Issue 2/2019

Login to get access

Abstract

Aims/hypothesis

Exercise is recommended for the treatment and prevention of type 2 diabetes. However, the most effective time of day to achieve beneficial effects on health remains unknown. We aimed to determine whether exercise training at two distinct times of day would have differing effects on 24 h blood glucose levels in men with type 2 diabetes.

Methods

Eleven men with type 2 diabetes underwent a randomised crossover trial. Inclusion criteria were 45–68 years of age and BMI between 23 and 33 kg/m2. Exclusion criteria were insulin treatment and presence of another systemic illness. Researchers were not blinded to the group assignment. The trial involved 2 weeks of either morning or afternoon high-intensity interval training (HIIT) (three sessions/week), followed by a 2 week wash-out period and a subsequent period of the opposite training regimen. Continuous glucose monitor (CGM)-based data were obtained.

Results

Morning HIIT increased CGM-based glucose concentration (6.9 ± 0.4 mmol/l; mean ± SEM for the exercise days during week 1) compared with either the pre-training period (6.4 ± 0.3 mmol/l) or afternoon HIIT (6.2 ± 0.3 mmol/l for the exercise days during week 1). Conversely, afternoon HIIT reduced the CGM-based glucose concentration compared with either the pre-training period or morning HIIT. Afternoon HIIT was associated with elevated thyroid-stimulating hormone (TSH; 1.9 ± 0.2 mU/l) and reduced T4 (15.8 ± 0.7 pmol/l) concentrations compared with pre-training (1.4 ± 0.2 mU/l for TSH; 16.8 ± 0.6 pmol/l for T4). TSH was also elevated after morning HIIT (1.7 ± 0.2 mU/l), whereas T4 concentrations were unaltered.

Conclusions/interpretation

Afternoon HIIT was more efficacious than morning HIIT at improving blood glucose in men with type 2 diabetes. Strikingly, morning HIIT had an acute, deleterious effect, increasing blood glucose. However, studies of longer training regimens are warranted to establish the persistence of this adverse effect. Our data highlight the importance of optimising the timing of exercise when prescribing it as treatment for type 2 diabetes.
Literature
6.
go back to reference Deschenes MR, Kraemer WJ, Bush JA et al (1998) Biorhythmic influences on functional capacity of human muscle and physiological responses. Med Sci Sports Exerc 30(9):1399–1407PubMed Deschenes MR, Kraemer WJ, Bush JA et al (1998) Biorhythmic influences on functional capacity of human muscle and physiological responses. Med Sci Sports Exerc 30(9):1399–1407PubMed
10.
go back to reference Nygaard H, Rønnestad BR, Hammarström D, Holmboe-Ottesen G, Høstmark AT (2017) Effects of exercise in the fasted and postprandial state on interstitial glucose in hyperglycemic individuals. J Sports Sci Med 16(2):254–263PubMedPubMedCentral Nygaard H, Rønnestad BR, Hammarström D, Holmboe-Ottesen G, Høstmark AT (2017) Effects of exercise in the fasted and postprandial state on interstitial glucose in hyperglycemic individuals. J Sports Sci Med 16(2):254–263PubMedPubMedCentral
Metadata
Title
Afternoon exercise is more efficacious than morning exercise at improving blood glucose levels in individuals with type 2 diabetes: a randomised crossover trial
Authors
Mladen Savikj
Brendan M. Gabriel
Petter S. Alm
Jonathon Smith
Kenneth Caidahl
Marie Björnholm
Tomas Fritz
Anna Krook
Juleen R. Zierath
Harriet Wallberg-Henriksson
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 2/2019
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-018-4767-z

Other articles of this Issue 2/2019

Diabetologia 2/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.